1999
DOI: 10.1097/00005344-199901000-00002
|View full text |Cite
|
Sign up to set email alerts
|

Increase in Circulating Endothelial Cells in Patients with Primary Chronic Venous Insufficiency: Protective Effect of Ginkor Fort in a Randomized Double-Blind, Placebo-Controlled Clinical Trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(13 citation statements)
references
References 14 publications
0
13
0
Order By: Relevance
“…In a randomized double-blind placebo-controlled clinical trial Ginkgo biloba extract, troxerutine, and heptaminol (Ginkor Fort) were tested for their venotropic protective effect in patients with CVI. The treated patient had decreased circulating endothelial cells, supporting venoprotective effects of these compounds against the endothelial cell injury associated with venous disease [92]. Daflon 500, a combination of active venotonic diosmin and the inactive compound hesperidin, is formulated as a micronized purified flavonoid fraction for increased absorption.…”
Section: Management Of Varicose Veinsmentioning
confidence: 88%
“…In a randomized double-blind placebo-controlled clinical trial Ginkgo biloba extract, troxerutine, and heptaminol (Ginkor Fort) were tested for their venotropic protective effect in patients with CVI. The treated patient had decreased circulating endothelial cells, supporting venoprotective effects of these compounds against the endothelial cell injury associated with venous disease [92]. Daflon 500, a combination of active venotonic diosmin and the inactive compound hesperidin, is formulated as a micronized purified flavonoid fraction for increased absorption.…”
Section: Management Of Varicose Veinsmentioning
confidence: 88%
“…Janssens et al found that in patients treated with GBE the number of circulating endothelial cells was decreased by the end of four weeks of treatment (20). It is suggested that GBE affects endothelium in a way that is potentially beneficial in chronic venous insufficiency.…”
Section: Clinical Use In Venous Insufficiencymentioning
confidence: 99%
“…C irculating endothelial cells (CEC) have been described in various conditions with vascular injury, including chronic renal failure and systemic vasculitis (1)(2)(3)(4)(5)(6)(7)(8)(9)(10). These studies indicate the existence of two types of cells in peripheral blood: endothelial progenitor cells (EPC) that are bone marrow derived and inflammatory endothelial cells (IEC) that are thought to be detached from the vessel walls and enter the circulation as a result of vascular injury.…”
mentioning
confidence: 99%